Watch for effectiveness of the resale registration statement, which triggers issuance of the commitment shares. The true-up provision leaves a $1M cash liability that may hit within 120 days of the Measurement Date. Expect continued downward pressure on GCTK from the dilutive overhang of this ELOC structure.
Price Chart
Executive Summary
Glucotrack amended its ELOC agreement with White Lion Capital to issue 2,505,513 commitment shares upon registration effectiveness, with a possible cash true-up if the Commitment Fee Price is below Minimum Price. The amendment formalizes a $1M commitment fee payable in shares, creating certain dilution but closing a previous future-dilution-avoidance path. The net effect on a $4M market cap company leaning on equity financing is bearish.
Key Financial Metrics
Key Facts
- Amends July 14, 2026 ELOC Purchase Agreement with White Lion Capital.
- Issues 2,505,513 commitment shares upon registration effectiveness, calculated as $1,000,000 divided by Minimum Price.
- True-up provision: if Commitment Fee Price < Minimum Price, Glucotrack owes cash difference up to $1,000,000 within 120 days.
- Shares issued under Section 4(a)(2) and Rule 506(b) as unregistered securities.
- Company market cap ~$4M; 2.5M commitment shares represent a large potential dilution relative to outstanding shares.
Financial Impact
Commitment shares of 2,505,513 issued for a $1,000,000 fee. On a $4M market cap, this represents ~25%+ dilution at current prices (before any true-up). True-up could add further cash cost up to $1M if Commitment Fee Price < Minimum Price.
Risk Factors
- Severe dilution from 2.5M commitment shares issuance on a micro-cap base.
- Potential cash true-up obligation up to $1,000,000 if the Commitment Fee Price is below Minimum Price.
- Reliance on ELOC financing signals capital constraints; no other funding sources disclosed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-036858 |
| Exhibit: ex10-1.htm | 0001493152-26-036858 |
| Document: 0001493152-26-036858-index-headers.html | 0001493152-26-036858 |
| Document: 0001493152-26-036858-index.html | 0001493152-26-036858 |
| Document: 0001493152-26-036858.txt | 0001493152-26-036858 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $0.4032 | awaiting T+60 | — | $1.61 (−299.31%) |
Oct 19, 2026 7d ago | 8-K | $0.6511 | awaiting T+60 | — | $1.61 (+147.27%) |
Oct 13, 2026 13d ago | S-1/A | $0.8873 | awaiting T+60 | — | $1.61 (−81.45%) |
Oct 13, 2026 13d ago | 425 | $0.8873 | awaiting T+60 | — | $1.61 (+81.45%) |
Sep 28, 2026 28d ago | 8-K | $1.74 | awaiting T+60 | — | $1.61 (−7.47%) |
Sep 24, 2026 4w ago | 424B5 | $1.82 | awaiting T+60 | — | $1.61 (+11.54%) |
Sep 24, 2026 4w ago | 8-K | $1.82 | awaiting T+60 | — | $1.61 (+11.54%) |
Sep 23, 2026 4w ago | 425 | $2.03 | awaiting T+60 | — | $1.61 (−20.69%) |
Sep 23, 2026 4w ago | 8-K | $2.03 | awaiting T+60 | — | $1.61 (−20.69%) |
Sep 18, 2026 5w ago | 8-K | $2.30 | awaiting T+60 | — | $1.61 (−30.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers